GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

MaxCyte MXCT · USD

Health Care · US listing · 🇺🇸 United States

Compare

1.30

+3.17%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on MaxCyte

Our reporting

We have not reported on MaxCyte yet.

Next results

10 Nov 2026

Due on 10 Nov 2026. Analysts expect earnings of -0.08 a share on revenue of $7.4m.

Past results

Reported against what analysts expected

12 Aug 202612 May 20266 May 202624 Mar 202612 Nov 20256 Aug 2025
Earnings per share-0.08-0.04-0.10-0.06-0.12-0.12
Forecast-0.09-0.10-0.09-0.08-0.11-0.10
Revenue$7.3m$9.7m—$7.3m$6.8m$8.5m
Forecast$6.5m$7.3m—$9.1m$9.4m$10.4m

Key events

  1. 29 Mar 2016Listed

MaxCyte in the news

Headlines from other publishers, linked to their own pages.

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.